EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›BLND

BLND

Blend Labs, Inc.

Last earnings +1.3% on 2026-05-07

Hold
$1.81
▲ +7.10%
$1.81▼ -44.14%
over 1Y
L $1.38EODHDH $4.34
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.1%
1W+11.7%
1M+9.0%
3M-9.5%
YTD-40.1%
1Y-44.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy

Real turnaround — losses nearly gone, no debt, cash-flow positive — but sub-7% growth and P/S 3.7 leave no bargain.

Revenue (FY2025) $124M (YoY +6.8%) · FY2025

Blend is a credible turnaround that isn't yet a quality business. The bottom line has healed dramatically: net loss narrowed to -$6.80M in FY2025 from -$43.3M (FY2024), -$179M (FY2023) and a -$720M blowout in FY2022, and operating cash flow swung to +$11.5M (+188%). Gross margin of 73.8% is genuinely SaaS-grade, and the balance sheet carries zero long-term debt, $43.6M cash and a ~2.4x current ratio ($139M current assets vs. $57.6M current liabilities) — enough runway to finish the job. That combination is why this is a hold, not an avoid.

But the quality bar isn't cleared. Revenue is $124M, roughly half the $234–235M of 2021–2022 (partly the Title segment reclassified to discontinued ops, per Note 16), and forward growth is only +6.8% — thin for a name at P/S 3.7. The company still loses money at the operating line (-17.6% margin), equity is negative (-$17.2M) against a -$1.39B accumulated deficit, and R&D was cut 28.7%, which flatters near-term cash but questions the growth engine. The MD&A confirms a success-based, self-reported revenue model that is hard to forecast and, per the Risk Factors, 'substantially dependent' on mortgage volumes and 'adversely affected' by higher rates — so the improving trend is levered to a cycle management doesn't control.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$234M$235M$110M$116M$124M
Gross profit$116M$89.7M$76.5M$83.2M$91.2M
Operating income-$197M-$746M-$144M-$48.8M-$21.7M
Net income-$170M-$720M-$179M-$43.3M-$6.80M
Diluted EPS-$1.30-$3.28-$0.76-$0.24-$0.10
Net margin-72.5%-306.2%-163.1%-37.4%-5.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$395M
EV / EBITDA—
EV / Sales3.2
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-1.6%
FCF yield-0.0%

Quality & risk

ROIC (est.)—
Free cash flow-$81.0K
Total debt$0.00
Net cash$43.6M
Altman Z-Score-5.14 distress
Piotroski F-Score7/9

Capital returns

Buyback yield5.7%
Dividend yield (est.)—
Shareholder yield5.7%
Shares Δ YoY-0.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Shareholder vote2026-06-23

    Item 5.07: annual meeting vote results certified; directors elected as proposed

  2. 8-K Earnings results2026-05-07

    Q1 2026: reports on continuing ops only after Title segment divestiture

  3. 10-Q Quarterly report2026-05-07

    Q1 2026: reports on continuing ops only after Title segment divestiture

  4. DEF 14A Proxy statement2026-04-29

    2026 proxy: board slate and executive comp put to annual meeting

  5. 10-K Annual report2026-03-16

    FY2025 loss cut to $6.8M, OCF +$11.5M; but two ICFR material weaknesses flagged

  6. 8-K Earnings results2026-03-10

    FY2025 results: revenue +7%, net loss narrowed ~84% to $6.8M, OCF turned positive

  7. 8-K Reg FD disclosure2026-03-02

    Reg FD (7.01) investor/conference disclosure; no financial change

  8. 8-K Reg FD disclosure2026-01-06

    Reg FD disclosure with exhibit; no material financial change

  9. 8-K Earnings results2025-11-06

    Q3 2025: Title business reclassified as discontinued operations

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-172026-06-23open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-06-172026-06-22open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-112026-06-15open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueB
GrowthA-
ProfitabilityF
Financial healthF
MomentumF
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Liabilities below 2× equity
1.3852-week4.37
Revenue
$124M
+6.8% YoY
Net margin
-5.5%
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$124M+6.8%
Net income-$6.80M+84.3%
Gross profit$91.2M+9.5%
Operating income-$21.7M+55.5%
Diluted EPS-$0.10+58.3%
Cash & equivalents$43.6M+1.3%
Total assets$187M+5.3%
Total liabilities$58.8M+45.5%
Stockholders' equity-$17.2M+69.5%
Gross: 73.8%Op.: -17.6%L/E: -3.42x

Frequently asked

Is Blend Labs, Inc. (BLND) a buy?
BLND currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Real turnaround — losses nearly gone, no debt, cash-flow positive — but sub-7% growth and P/S 3.7 leave no bargain.
What is Blend Labs, Inc.'s quality score?
BLND scores 44.575122202212505/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001855747, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 7/3/2026, 5:13:10 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 3 open-market buys · 0 sales

2026-06-15
Haveli Investments, L.P.
Director
Buy650K @ $1.72$1.12M
2026-06-12
Haveli Investments, L.P.
Director
Buy257K @ $1.70$436K
2026-06-11
Haveli Investments, L.P.
Director
Buy250K @ $1.74$435K
2026-06-11
Woersching Eric H.
Director
Exercise50.0K
2026-06-11
Sullivan Bryan Edmund
Director
Exercise50.0K

Earnings history

beat/miss · move
2026-05-07Miss -100.0% est▲ +1.25%8-K ↗
2026-03-10Miss -100.0% est▼ -2.40%8-K ↗
2025-11-06Miss -100.0% est▼ -7.14%8-K ↗
2025-08-07Miss -100.0% est▼ -0.28%8-K ↗
2025-05-08—▲ 0.00%8-K ↗
2025-02-27—▼ -3.57%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Blend Labs (BLND): One of the Best Stocks with Biggest UpsideBullish
finance.yahoo.com· 2026-06-26
Segro bid boosts FTSE 100 as gold and oil sinkBullish
uk.finance.yahoo.com· 2026-06-24
Fintech M&A Watch: 3 Stocks That Could Be Next on the BlockBullish
finance.yahoo.com· 2026-06-09
Should You Be Adding British Land (LON:BLND) To Your Watchlist Today?Bullish
finance.yahoo.com· 2026-06-04
Here is What the Street is Saying About Blend Labs (BLND) Following Q1Bullish
finance.yahoo.com· 2026-06-02
Stocks climb but BP knocked by chairman’s sudden exitBullish
uk.finance.yahoo.com· 2026-05-26

Vs tracked universe

compare →

1196 tracked peers · median

EDGAR Score45 vs 67
Revenue growth6.8% vs 7.5%
Net margin-5.5% vs 10.0%
Return on equity— vs 11.9%
P/E— vs 26.3

News sentiment

EODHD · 8d
Bullish
+0.09
vs typical · 8 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.